ETS-ASSOCIATED GENOMIC ALTERATIONS INCLUDING ETS2 LOSS MARKEDLY AFFECT PROSTATE CANCER PROGRESSION

$124,094FY2013Department of DefenseDOD

Sloan-Kettering Institute For Cancer Research

Investigators